Drug Type Bispecific T-cell Engager (BiTE) |
Synonyms ciduvectamig |
Target |
Mechanism CD3ε inhibitors(CD3e molecule inhibitors), TMEFF2 inhibitors(Tomoregulin-2 inhibitors) |
Therapeutic Areas- |
Active Indication- |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest PhaseClinical |
First Approval Date- |
Regulation- |